Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptor Blockade”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Early research (Phase 1)Study completedNCT01582399
What this trial is testing

Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240

Who this might be right for
Pharmacokinetics of ASKP1240Pharmacodynamics of ASKP1240Healthy Volunteers
Astellas Pharma Global Development, Inc. 24
Large-scale testing (Phase 3)Active Not RecruitingNCT02490904
What this trial is testing

Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)

Who this might be right for
End-stage Renal Disease
Central Hospital, Nancy, France 132
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Not applicableStudy completedNCT00625014
What this trial is testing

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

Who this might be right for
Insulin ResistanceDyslipidemia
Leiden University Medical Center 8
Testing effectiveness (Phase 2)Ended earlyNCT03071094
What this trial is testing

A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Transgene 14
Not applicableEnded earlyNCT00980031
What this trial is testing

Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension

Who this might be right for
Myocardial Remodeling
Creighton University 20
Testing effectiveness (Phase 2)UnknownNCT02944201
What this trial is testing

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Montefiore Medical Center 22
Large-scale testing (Phase 3)Study completedNCT00256698
What this trial is testing

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Who this might be right for
Breast Cancer
AstraZeneca 514
Not applicableUnknownNCT03461107
What this trial is testing

Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure

Who this might be right for
Heart Failure
Tongji Hospital 2,500
Testing effectiveness (Phase 2)Study completedNCT00502528
What this trial is testing

Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction

Who this might be right for
ST-Elevation Myocardial Infarction
Medical University of Vienna 57
Very early researchLooking for participantsNCT03068910
What this trial is testing

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Who this might be right for
HyperandrogenismPolycystic Ovary SyndromePuberty
University of Virginia 32
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT04675827
What this trial is testing

De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

Who this might be right for
HER2-positive Breast CancerER-Negative Breast CancerPR-Negative Breast Cancer+1 more
Jules Bordet Institute 139
Large-scale testing (Phase 3)Study completedNCT01052272
What this trial is testing

Impact of Diabetes on Left Ventricular Remodeling

Who this might be right for
Diabetes
University of Alabama at Birmingham 72
Not applicableStudy completedNCT00675051
What this trial is testing

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
University of California, San Francisco 20
Testing effectiveness (Phase 2)Ended earlyNCT00194792
What this trial is testing

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+3 more
University of Washington 28
Very early researchStudy completedNCT03738943
What this trial is testing

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

Who this might be right for
Receptor Blockade
Colorado State University 9
Testing effectiveness (Phase 2)UnknownNCT01658410
What this trial is testing

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Who this might be right for
Coronary Artery DiseaseAorto-coronary Bypass Grafting
Medical University of Vienna 120
Not applicableNot Yet RecruitingNCT07223372
What this trial is testing

An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia

Who this might be right for
Metastatic Hormonesensitive Prostate Cancer (mHSPC)
Bayer 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05281003
What this trial is testing

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Load More Results